This Article Full Text (PDF) Other Versions of this Article: JVI.00900-06v1 80/23/11510    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yuan, J. Articles by Yang, D. Search for Related Content PubMed PubMed Citation Articles by Yuan, J. Articles by Yang, D.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.00900-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Inhibition of Coxsackievirus B3 in Cell-cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the IRES

The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia, Vancouver, British Columbia, Canada, AVI BioPharma, Inc., Corvallis, Oregon, USA

^* To whom correspondence should be addressed. Email: dyang{at}mrl.ubc.ca.

	Abstract

Coxsackievirus B3 (CVB3) is a primary cause of viral myocarditis, yet no effective therapeutic against CVB3 is available. Nucleic acid-based interventional strategies against various viruses, including CVB3, have shown promise experimentally, but limited stability and inefficient delivery in vivo remain as obstacles to their potential as therapeutics. We employed phosphorodiamidate morpholino oligomers (PMO) conjugated to a cell-penetrating arginine-rich peptide (to form ‘PPMO’) to address these issues. Eight CVB3-specific PPMO were evaluated in HeLa cells and HL-1 cardiomyocytes in culture, and in a murine infection model. One of the PPMO (PPMO-6), designed to target sequence in the 3' portion of the CVB-3 internal ribosomal entry site, was found to be especially potent against CVB3. Treatment of cells with PPMO-6 prior to CVB3 infection produced an approximately 3 log₁₀ decrease in viral titer, and largely protected cells from viral-induced cytopathic effect. A similar antiviral effect was observed when PPMO-6 treatment began shortly after the virus infection period. A/J mice receiving intravenous administration of PPMO-6 once prior to and once after CVB3 infection showed approximately 2 log₁₀ less viral titer in myocardium at seven days post-infection, and a significantly decreased level of cardiac tissue damage, compared to controls. Thus, PPMO-6 provided potent inhibition of CVB3 amplification both in cell culture and in vivo, and appears worthy of further evaluation as a candidate for clinical development.

This article has been cited by other articles:

• Stone, J. K., Rijnbrand, R., Stein, D. A., Ma, Y., Yang, Y., Iversen, P. L., Andino, R. (2008). A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus. Antimicrob. Agents Chemother. 52: 1970-1981 [Abstract] [Full Text]  
• Gabriel, G., Nordmann, A., Stein, D. A., Iversen, P. L., Klenk, H.-D. (2008). Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus. J. Gen. Virol. 89: 939-948 [Abstract] [Full Text]  
• Zhang, Y.-J., Bonaparte, R. S., Patel, D., Stein, D. A., Iversen, P. L. (2008). Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus. Molecular Cancer Therapeutics 7: 712-720 [Abstract] [Full Text]  
• Vagnozzi, A., Stein, D. A., Iversen, P. L., Rieder, E. (2007). Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino Oligomers. J. Virol. 81: 11669-11680 [Abstract] [Full Text]  
• Wu, R. P., Youngblood, D. S., Hassinger, J. N., Lovejoy, C. E., Nelson, M. H., Iversen, P. L., Moulton, H. M. (2007). Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res 0: gkm478v1-10 [Abstract] [Full Text]  
• Deas, T. S., Bennett, C. J., Jones, S. A., Tilgner, M., Ren, P., Behr, M. J., Stein, D. A., Iversen, P. L., Kramer, L. D., Bernard, K. A., Shi, P.-Y. (2007). In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile Virus. Antimicrob. Agents Chemother. 51: 2470-2482 [Abstract] [Full Text]  
• Burrer, R., Neuman, B. W., Ting, J. P. C., Stein, D. A., Moulton, H. M., Iversen, P. L., Kuhn, P., Buchmeier, M. J. (2007). Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection Models. J. Virol. 81: 5637-5648 [Abstract] [Full Text]